Difference between revisions of "Chikuma S, et al. Cancer Sci. (2017) cited as Ref 311 in DOI: 10.1038/s41392-020-0110-5 (Q9574)"
Jump to navigation
Jump to search
(Created claim: First Author string (P149): Chikuma S, #quickstatements; #temporary_batch_1589996169159) |
(Created claim: Fourth Author string (P152): Yoshimura A, #quickstatements; #temporary_batch_1590155310798) |
||||||||||||||
| (9 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / Second Author string | |||||||||||||||
| + | Kanamori M | ||||||||||||||
| Property / Second Author string: Kanamori M / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Third Author string | |||||||||||||||
| + | Mise-Omata S | ||||||||||||||
| Property / Third Author string: Mise-Omata S / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / DOI Identifier | |||||||||||||||
| + | |||||||||||||||
| Property / DOI Identifier: 10.1111/cas.13194 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / PubMed ID | |||||||||||||||
| + | |||||||||||||||
| Property / PubMed ID: 28188673 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Publication Date | |||||||||||||||
| + | 2017
| ||||||||||||||
| Property / Publication Date: 2017 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Published In Name String | |||||||||||||||
| + | Cancer Sci. | ||||||||||||||
| Property / Published In Name String: Cancer Sci. / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Volume | |||||||||||||||
| + | 108 | ||||||||||||||
| Property / Volume: 108 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / title | |||||||||||||||
| + | Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy (English) | ||||||||||||||
| Property / title: Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy (English) / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Page(s) | |||||||||||||||
| + | 574-580 | ||||||||||||||
| Property / Page(s): 574-580 / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
| Property / Fourth Author string | |||||||||||||||
| + | Yoshimura A | ||||||||||||||
| Property / Fourth Author string: Yoshimura A / rank | |||||||||||||||
| + | Normal rank | ||||||||||||||
Latest revision as of 13:49, 22 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Chikuma S, et al. Cancer Sci. (2017) cited as Ref 311 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Chikuma S
0 references
Kanamori M
0 references
Mise-Omata S
0 references
2017
0 references
Cancer Sci.
0 references
108
0 references
Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy (English)
0 references
574-580
0 references
Yoshimura A
0 references
